Advocates for Alzheimer's and dementia research applauded a $100 million increase in funding, approved by Congress and signed ...
SAN DIEGO, Jan. 6, 2026 /PRNewswire/ -- Novoron Bioscience, a San Diego-based biotechnology company developing therapies for neurodegenerative diseases and neurological injury, has received a $2.5 ...
COLLEGE STATION, Texas — A Texas A&M University researcher received a multi-million-dollar grant to advance brain cell ...
Oligomerix, Inc., a privately held clinical stage company pioneering the development of oral, small molecule therapeutics targeting Alzheimer’s (AD) and rare neurodegenerative diseases, announced an ...
This award will enable the expansion of patient cohort data and accessibility to the test, both of which are critical for commercialization as a diagnostic test.” — Dr. Michael Reed, Chief Development ...
The Indiana University School of Medicine hopes to make significant advancements in Alzheimer’s disease research thanks to a new $16.5 million federal grant. The five-year grant from the National ...
Pause on federal funding could cost Huntsville’s HudsonAlpha millions for crop, Alzheimer’s research
HudsonAlpha Institute for Biotechnology in Huntsville is facing the loss of millions of dollars in federal funding due to a shift in priorities by the Trump Administration. Just how much of a loss ...
Philadelphia biotechs are worried about losing a key source of federal funding for early-stage innovation. Known as “America’s seed fund,” the Small Business Innovation Research (SBIR) and Small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results